This case highlights the diagnostic challenge of PCD, particularly when neurological manifestations precede tumor detection, and suggests that HER2-positive breast cancer may also be associated with anti-Yo antibodies. This evidence concerns the gene ERBB2 and paraneoplastic neurologic syndrome.